Pressemitteilung BoxID: 367775 (aap Implantate AG)
  • aap Implantate AG
  • Lorenzweg 5
  • 12099 Berlin
  • Ansprechpartner
  • Marc Heydrich
  • +49 (30) 75019-134

aap Implantate AG Launches Free Investor Relations "App"

Downloadable mobile app available at Apple's App store and Google Play

(lifePR) (Berlin, ) aap Implantate AG, (XETRA: AAQ.DE), a global medical device company focused on innovative trauma products and biomaterials for the orthopaedic market, announced the launch of a free investor relations "app" for the iPhone, iPad and Android mobile devices. The aap investor relations app is available at Apple's App Store for the iPhone and iPad and at Google Play for Android mobile devices.

The aap Implantate AG investor relations app allows users to navigate the Company's investor relations materials as well as receive a stock quote and other important stock information. Features in the app include the latest press releases and corporate documents, as well as presentations from the Company. It provides sharing functionality via email and the ability to be notified when new information is posted to the company's IR app.

Biense Visser, Chief Executive Officer of aap Implantate AG, said, "We recognize the growing importance of mobile technology for the global investment community and the launch of this app helps ensure that our investors have instant mobile access to our corporate and stock information. From now on, we will also communicate all upcoming news through the app. The app provides another forum for our investors to receive these important updates and to share their interest in aap with colleagues and friends."

To download the app immediately, you can also scan the following QR-code with an appropriate app. This code will automatically detect which device (iPhone, iPad, or Android) the user used for scanning the code and begin the download automatically.

aap Implantate AG

aap is a global medical device company headquartered in Berlin, Germany that develops, manufactures and markets innovative biomaterials and implants that are used in orthopedic procedures. The Company's products, which include a full line of plating systems, cannulated screws and bone cement products, are primarily used in the orthopedic specialty areas of trauma and spine repair. The Company's products are sold through its direct sales force, distribution partners and license agreements with OEM partners. aap's stock is listed in the Prime Standard segment of the Frankfurt Stock Exchange. For more information, please visit, or download the Company's investor relations app from the Apple's App Store or Google Play.